Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

LumiraDx Limited LMDX NASDAQ

NASDAQ Global Market • Healthcare • Medical - Diagnostics & Research • GB • USD

SharesGrow Score
44/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$1.50
+9275%

LumiraDx Limited (LMDX) has 11 identified peers for comparison in the Healthcare sector. Peers include BDSX, BNR, DRIO, ENZ, FONR, GTH and others.

LMDX has a market capitalization of $5.1M, compared to an average peer market cap of $761.04M. LMDX is notably smaller than its average peer.

People Also View

SHC
SHC
Sotera Health Company
$15.93
+1.46%
 OLK
OLK
Olink Holding AB (publ)
$26.08
+0.31%
 GTH
GTH
Genetron Holdings Limited
$4.03
+0.12%
 FONR
FONR
FONAR Corporation
$18.76
+0.27%
 BDSX
BDSX
Biodesix, Inc.
$12.14
-9.13%
 SERA
SERA
Sera Prognostics, Inc.
$2.14
+0.47%
 XGN
XGN
Exagen Inc.
$3.04
+2.36%
 DRIO
DRIO
DarioHealth Corp.
$7.56
+3.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message